DSM

DSM is a leading producer of: life science products, performance materials, industrial chemicals. DSM develops a broad range of medicinal feedstock, for instance, to treat AIDS, Alzheimer’s disease, cardio-vascular disease, obesity, and malaria. DSM is the world market leader in antibiotics and chiral products.
Vision 2005: Focus and Value is the company strategy that will carry DSM to a turnover level of € 10 billion by 2005. About 80% of this will come from specialties such as high-quality biotech and chemical products and materials. These, in turn, make their way to the pharmaceutical industry, food sectors, the automotive market, and to manufacturers of electrical equipment and electronics.
2002: DSM announced the intended sale of its petrochemicals business to SABIC

Activity:

- Manufacturing

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Pharmaceuticals / Therapeutics

Therapeutic targets:

- AIDS
- Alzheimer's Disease
- Cardiovascular
- Epidemiology
- Infectious Diseases
- Obesity

Markets Covered

a. HeadQuarter: Netherlands

b. Continent(s) active: Europe , North America , Central/South America , Asia

c. Countries active: 200 offices and production sites in 40 countries

Corporate data:

Number of Employees: 21504 (50% in Netherlands)

Turnover:

Amount:	Year:	Currency:
7970000000	2001	Euro

Year founded: 1902